InsiderFlow

ABERNETHY MATT

NBIX

ABERNETHY MATT serves as officer: Chief Financial Officer at Neurocrine Biosciences, Inc. (NBIX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

16 trades

$12.29M

Net Position

Net Seller

$12.29M

Companies Traded

1

NBIX

Active Period

Dec 2021 – Sep 2026

16 total trades

Most Recent

Sell NBIX

Sep 15, 2026 · $363.3K

ABERNETHY MATT's Insider Trading at Neurocrine Biosciences, Inc. (NBIX)

Buys

0 · $0.00

Sells

16 · $12.29M

Total Shares Bought

0

Total Shares Sold

98,711

NBIX Price Chart
Loading chart...
DateTypeValue
Sep 15, 2026 Sell$363.3K
Feb 12, 2026 Sell$463.8K
Feb 14, 2025 Sell$298.9K
Feb 12, 2025 Sell$115.9K
Feb 4, 2025 Sell$196.1K
Aug 15, 2024 Sell$2.12M
Jul 18, 2024 Sell$135.0K
May 16, 2024 Sell$4.14M
Feb 15, 2024 Sell$179.6K
Feb 8, 2024 Sell$313.5K
Feb 2, 2024 Sell$180.5K
Aug 23, 2023 Sell$229.0K
Feb 8, 2023 Sell$2.93M
Feb 2, 2023 Sell$141.1K
Feb 9, 2022 Sell$345.5K
Dec 3, 2021 Sell$135.9K